• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Sangamo strikes TxCell takeover to gain CAR-Treg pipeline fiercebiotech
    July 26, 2018
    Sangamo Therapeutics is set to acquire TxCell for its CAR-Treg platform and pipeline. The €72 million ($84 million) takeover will position Sangamo to move a CAR-carrying regulatory T cell candidate into testing in solid organ transplant patients next year

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service